Matthew J Dodds

Analyst Matthew J Dodds of Citi Investment Research & Analysis maintains his "buy" rating on Covidien Ltd (NYSE: COV), while raising his estimates for the company. The target price for COV has been raised from $53 to $56. According to Citi Investment Research & Analysis, Covidien’s gross...